Literature DB >> 23509588

The MyHealthCheckup study: Training graduate students to implement cardiovascular risk screening programs in community pharmacies.

Hailey R Banack, Samuel Grover, Mohammed Kaouche, Sylvie Marchand, Ilka Lowensteyn.   

Abstract

BACKGROUND: Hypertension is a major risk factor for cardiovascular morbidity and mortality. Despite this fact and the development of effective antihypertensive drug therapy, hypertension is often poorly controlled. Community pharmacies are an ideal site for the management of hypertension and other modifiable cardiovascular risk factors. The purpose of the current study was to develop and assess a pharmacy-based cardiovascular risk screening program implemented by graduate students.
METHODS: Four graduate students trained as health coaches screened a convenience sample of adults who were interested in cardiovascular risk assessment in 21 Montreal area pharmacies. On the screening day, we assessed cardiovascular risk factors, including blood pressure, used the Cardiovascular Life Expectancy Model, which includes cardiovascular age, to inform patients of their personalized risk profile, delivered an individualized health coaching intervention and conducted a participant satisfaction survey. This was followed by an individualized health coaching intervention. The intervention program was implemented by trained graduate students and supported by pharmacists.
RESULTS: Among the 238 patients who participated (57% female, mean age 60.6 years), 67% had a body mass index (BMI) greater than 25 kg/m(2), 52% had abdominal obesity, 58% reported insufficient physical activity and 14% were smokers. A total of 120 patients (51%) were taking antihypertensive medication, yet 63 (53%) had blood pressure readings above currently accepted targets. Higher BMI and physical inactivity were associated with increased rates of poorly controlled hypertension.
CONCLUSION: The screening program identified individuals with modifiable cardiovascular risk factors and poorly controlled hypertension. The intervention program was well received by participants and the majority provided contact information for future cardiovascular screening clinics. These findings support the feasibility of screening programs run by graduate students in the pharmacy setting.

Entities:  

Year:  2012        PMID: 23509588      PMCID: PMC3567593          DOI: 10.3821/145.6.cpj268

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN: 1715-1635


  19 in total

1.  Pilot study for appropriate anti-infective community therapy. Effect of a guideline-based strategy to optimize use of antibiotics.

Authors:  J Stewart; J Pilla; L Dunn
Journal:  Can Fam Physician       Date:  2000-04       Impact factor: 3.275

2.  Blood pressure measuring devices: recommendations of the European Society of Hypertension.

Authors:  E O'Brien; B Waeber; G Parati; J Staessen; M G Myers
Journal:  BMJ       Date:  2001-03-03

3.  The role of community pharmacists in health education and disease prevention: a survey of their interests and needs in relation to cardiovascular disease.

Authors:  J O'Loughlin; P Masson; V Déry; D Fagnan
Journal:  Prev Med       Date:  1999-03       Impact factor: 4.018

4.  Pharmacists outside U.S. inch toward independent prescribing.

Authors:  Kate Traynor
Journal:  Am J Health Syst Pharm       Date:  2004-07-15       Impact factor: 2.637

5.  Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades.

Authors:  Finlay A McAlister; Kathryn Wilkins; Michel Joffres; Frans H H Leenen; George Fodor; Marianne Gee; Mark S Tremblay; Robin Walker; Helen Johansen; Norm Campbell
Journal:  CMAJ       Date:  2011-05-16       Impact factor: 8.262

Review 6.  Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials.

Authors:  Valérie Santschi; Arnaud Chiolero; Bernard Burnand; April L Colosimo; Gilles Paradis
Journal:  Arch Intern Med       Date:  2011-09-12

7.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Authors:  Sarah Lewington; Robert Clarke; Nawab Qizilbash; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

8.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Tony Dans; Alvaro Avezum; Fernando Lanas; Matthew McQueen; Andrzej Budaj; Prem Pais; John Varigos; Liu Lisheng
Journal:  Lancet       Date:  2004 Sep 11-17       Impact factor: 79.321

9.  Impact of major cardiovascular disease risk factors, particularly in combination, on 22-year mortality in women and men.

Authors:  L P Lowe; P Greenland; K J Ruth; A R Dyer; R Stamler; J Stamler
Journal:  Arch Intern Med       Date:  1998-10-12

10.  Development and preliminary testing of a patient decision aid to assist pharmaceutical care in the prevention of cardiovascular disease.

Authors:  Lyne Lalonde; Annette M O'Connor; Elizabeth Drake; Pierrette Duguay; Ilka Lowensteyn; Steven A Grover
Journal:  Pharmacotherapy       Date:  2004-07       Impact factor: 4.705

View more
  1 in total

1.  Outcomes of a multi-community hypertension implementation study: the American Heart Association's Check. Change. Control. program.

Authors:  Monique L Anderson; Rachel Peragallo Urrutia; Emily C O'Brien; Nancy M Allen LaPointe; Alexander J Christian; Lisa A Kaltenbach; Laura E Webb; Angel M Alexander; Paramita Saha Chaudhuri; Juliana Crawford; Patrick Wayte; Eric D Peterson
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-01-06       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.